Non-alcoholic steatohepatitis weakens the acute phase response to endotoxin in rats. 2014

Karen L Thomsen, and Lionel Hebbard, and Emilie Glavind, and Andrew Clouston, and Hendrik Vilstrup, and Jacob George, and Henning Grønbæk
Department of Hepatology & Gastroenterology, Aarhus University Hospital, Aarhus C, DK-8000, Denmark.

OBJECTIVE Patients with non-alcoholic steatohepatitis (NASH) have increased mortality, including from infections. We, therefore, tested in a rodent model of steatohepatitis whether the hepatic acute phase response is intact. METHODS Steatohepatitis was induced in rats by feeding a high-fat, high-cholesterol diet for 4 (early) and 16 weeks (advanced NASH). 2 h after low-dose LPS (0.5 mg/kg i.p.), we measured the serum concentrations of tumour necrosis factor-α (TNF-α) and interleukin-6 (IL-6). We also measured liver mRNA's and the serum concentrations of acute phase proteins 24 h after LPS. RESULTS Non-alcoholic steatohepatitis in itself increased the liver mRNA levels of TNF-α and IL-6 and also the liver mRNA and serum levels of the acute phase proteins. The exposure to LPS increased serum TNF-α in both early and advanced NASH and more so than in the control rats. However, the increases in acute phase protein genes in liver tissue and proteins in the blood were lower than in the control rats. CONCLUSIONS In rats with early or advanced experimental NASH, LPS despite an increased interleukin release resulted in a blunted acute phase protein response. This tachyphylaxis may be part of the mechanism for the increased infection susceptibility of patients with NASH. We speculate that the steatosis-related interleukin release desensitises the signalling pathway leading to acute phase protein synthesis.

UI MeSH Term Description Entries
D007118 Immunoassay A technique using antibodies for identifying or quantifying a substance. Usually the substance being studied serves as antigen both in antibody production and in measurement of antibody by the test substance. Immunochromatographic Assay,Assay, Immunochromatographic,Assays, Immunochromatographic,Immunoassays,Immunochromatographic Assays
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D004731 Endotoxins Toxins closely associated with the living cytoplasm or cell wall of certain microorganisms, which do not readily diffuse into the culture medium, but are released upon lysis of the cells. Endotoxin
D005260 Female Females
D000209 Acute-Phase Proteins Proteins that are secreted into the blood in increased or decreased quantities by hepatocytes in response to trauma, inflammation, or disease. These proteins can serve as inhibitors or mediators of the inflammatory processes. Certain acute-phase proteins have been used to diagnose and follow the course of diseases or as tumor markers. Acute Phase Reactant,Acute-Phase Glycoprotein,Acute-Phase Reactant,Acute-Phase Reactants,Proteins, Acute-Phase,Reactants, Acute-Phase,Acute-Phase Glycoproteins,Acute-Phase Protein,Acute Phase Glycoprotein,Acute Phase Glycoproteins,Acute Phase Protein,Acute Phase Proteins,Acute Phase Reactants,Glycoprotein, Acute-Phase,Glycoproteins, Acute-Phase,Phase Reactant, Acute,Protein, Acute-Phase,Proteins, Acute Phase,Reactant, Acute Phase,Reactant, Acute-Phase,Reactants, Acute Phase
D000210 Acute-Phase Reaction An early local inflammatory reaction to insult or injury that consists of fever, an increase in inflammatory humoral factors, and an increased synthesis by hepatocytes of a number of proteins or glycoproteins usually found in the plasma. Acute Phase Response,Acute-Phase State,Reaction, Acute-Phase,Response, Acute-Phase,Acute Phase Reaction,Acute Phase Responses,Acute Phase State,Acute-Phase Response,Phase Response, Acute,Reaction, Acute Phase,Response, Acute Phase,State, Acute-Phase
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha

Related Publications

Karen L Thomsen, and Lionel Hebbard, and Emilie Glavind, and Andrew Clouston, and Hendrik Vilstrup, and Jacob George, and Henning Grønbæk
January 2020, Microbial pathogenesis,
Karen L Thomsen, and Lionel Hebbard, and Emilie Glavind, and Andrew Clouston, and Hendrik Vilstrup, and Jacob George, and Henning Grønbæk
April 2011, Journal of gastroenterology and hepatology,
Karen L Thomsen, and Lionel Hebbard, and Emilie Glavind, and Andrew Clouston, and Hendrik Vilstrup, and Jacob George, and Henning Grønbæk
April 2008, Inflammation,
Karen L Thomsen, and Lionel Hebbard, and Emilie Glavind, and Andrew Clouston, and Hendrik Vilstrup, and Jacob George, and Henning Grønbæk
January 2017, Metabolism: clinical and experimental,
Karen L Thomsen, and Lionel Hebbard, and Emilie Glavind, and Andrew Clouston, and Hendrik Vilstrup, and Jacob George, and Henning Grønbæk
August 2012, Revista de gastroenterologia de Mexico,
Karen L Thomsen, and Lionel Hebbard, and Emilie Glavind, and Andrew Clouston, and Hendrik Vilstrup, and Jacob George, and Henning Grønbæk
August 2002, Orvosi hetilap,
Karen L Thomsen, and Lionel Hebbard, and Emilie Glavind, and Andrew Clouston, and Hendrik Vilstrup, and Jacob George, and Henning Grønbæk
January 2003, Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti,
Karen L Thomsen, and Lionel Hebbard, and Emilie Glavind, and Andrew Clouston, and Hendrik Vilstrup, and Jacob George, and Henning Grønbæk
January 2002, Revista de gastroenterologia de Mexico,
Karen L Thomsen, and Lionel Hebbard, and Emilie Glavind, and Andrew Clouston, and Hendrik Vilstrup, and Jacob George, and Henning Grønbæk
February 1989, Anales de medicina interna (Madrid, Spain : 1984),
Karen L Thomsen, and Lionel Hebbard, and Emilie Glavind, and Andrew Clouston, and Hendrik Vilstrup, and Jacob George, and Henning Grønbæk
January 2001, Le Journal medical libanais. The Lebanese medical journal,
Copied contents to your clipboard!